Skip to content
2000
Volume 1, Issue 2
  • ISSN: 1574-8871
  • E-ISSN: 1876-1038

Abstract

Alefacept is an immunobiologic agent that has been recently introduced in the treatment of plaque psoriasis. The author presents a brief review of the drug, its efficacy and safety profile. Recent case reports of the use of alefacept in conjunction with other conditions as well as the drug's possible use for treatment of other conditions are reviewed as

© Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/rrct/10.2174/157488706776876481
2006-05-01
2025-09-17

  • From This Site

    /content/journals/rrct/10.2174/157488706776876481
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/content/journals/rrct/10.2174/157488706776876481
Loading

  • Article Type:     Research Article
Keyword(s): immunosuppressive fusion protein; intramuscular injection; Psoriasis Area and Severity Index (PASI); psoriatic arthritis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test